Anaphylaxis is a life-threatening hypersensitivity reaction. To identify biomarkers for the condition, we assessed serum levels of apolipoprotein (Apo)A and ApoE. We found a reduction of both lipoproteins in anaphylactic mice as well as in orally challenged food allergic patients. We then compared patients after acute anaphylaxis with several control groups (nonallergic, history of allergen-triggered anaphylaxis, acute cardiovascular/febrile reactions). In this unpaired setting, ApoE levels were unaltered, while ApoA1 was reduced in the anaphylactic group. Although unable to discriminate between anaphylaxis and cardiovascular/febrile reactions, ROC curve analysis revealed a reasonably high area under the curve (AUC) of 0.91 for ApoA1.
| INTRODUCTION
Anaphylaxis is a rapid potentially life-threatening allergic reaction. 1, 2 Preformed and de novo synthesized mediators, 3 predominantly released by activated mast cells (MCs), or basophils 4 determine the outcome of this response. The diagnosis of anaphylaxis is based on the clinical reaction patterns as reliable biomarkers are sparse. Serum tryptase is the clinically available biomarker for anaphylaxis so far, but it is unable to detect all anaphylactic responses. 5, 6 We recently demonstrated 6 that serum levels of 9a,11ß-PGF 2 , a metabolite of PGD 2 , increase profoundly during anaphylaxis and display a higher sensitivity and specificity for anaphylaxis than tryptase. To identify additional diagnostic markers for anaphylaxis, we determined proteins with substantial changes during oral food challenge in sera of food allergic patients. Based on this protein identification report and the existing literature, 7 we analyzed mouse and human serum apolipoprotein (Apo)E and ApoA1 levels and assessed whether these mediators could serve as suitable biomarkers of anaphylaxis. Both belong to the high-density lipoproteins (HDL) and are involved in cholesterol transport and metabolism. 8, 9 It has been shown previously that HDL particles can be degraded by chymases and tryptases, released upon MC activation.
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2 | MATERIAL AN D METHODS
| Protein identification report
Sera derived from food allergic patients with a history of anaphylaxis were analyzed prior to and after oral challenge with the respective allergen. Proteins with substantial changes during the allergic reaction were identified using an MS/MS ion search 13 of the Mascot search engine (www.matrixscience) and a protein database (www. 
| Blood collection and analysis
We compared serum samples derived from anaphylactic or nonanaphylactic Balb/c mice (n=10/group for ApoE; n=8/group for ApoA1). Passive systemic anaphylaxis was induced as described previously. 14 In a matched setting, we compared human serum samples derived from food allergic patients with a history of anaphylaxis, taken before and within 15 minutes after oral allergen challenge ('before/after challenge', n=11, Table S1 ). In addition, we analyzed sera derived from patients with acute anaphylactic symptoms, admitted to the Emergency department. Blood was obtained within a maximum of 2 hours after the anaphylactic reaction ('after ANA', n= 10, Table S2 ). Anaphylaxis severity was assessed based on their clinical reaction patterns according to Ring and Messmer. 15 The control groups comprised of nonallergic subjects without any history of allergy, confirmed by negative skin prick test ('nonallergic', n=11, Table S3 ), patients with a history of anaphylaxis but without any symptoms at the time of blood withdrawal ('ANA prone', n=19, Table S4 ) and patients with acute cardiovascular/febrile reactions ('other diseases', n=12, Table S5 ). Serum levels of ApoE and ApoA1 were assessed by ELISA following the manufacturers' instructions (ApoE, human samples: Assaypro LLC, St
Charles, USA; ApoA1, human samples: Abcam plc, Cambridge, UK; ApoE, mouse samples: Cusabio, Hubei, China; ApoA1, mouse samples:
Cloud-Clone Corp., Houston, USA).
| Statistical analysis
Statistical analysis was performed with PRISM 6.0 (GraphPad Software, La Jolla, CA, USA) using (non)parametric ANOVA with Dunn's or Holm-Sidak's post-test or the Mann-Whitney test. Paired samples were analyzed using the Wilcoxon matched-pairs test. A P-value of 0.05 was considered statistically significant. Receiver operating characteristic (ROC) curves and areas under the curve (AUCs) were calculated to determine the predictive power using the 'pROC' package for the R statistic computing platform (www.R-project.org). An AUC equal to 1.0 indicates that the diagnostic test discriminates perfectly between anaphylaxis and 'no anaphylaxis'. An AUC equal to 0.5 indicates that the results are purely random.
| RESULTS
Initially, we analyzed mouse serum ApoE and ApoA1 levels after PSA induction and compared them with those of a control group without anaphylaxis. ApoE and ApoA1 decreased after anaphylaxis in the mouse ( Figure 1A,B) . To investigate the validity in human samples, we analyzed matched serum samples from food allergic patients with a history of anaphylaxis, taken before and after a positive oral allergen challenge (Table S1 ). Consistent with the data from mice, ApoE and ApoA1 levels decreased in patients with objective allergic responses ( Figure 1C,D) . In addition, we compared sera from anaphylactic patients (Table S2 ) with sera of several control groups (nonallergic subjects, Table S3 ; patients with a history of anaphylaxis in the past but without symptoms at the time of blood withdrawal, Table S4 and patients with acute cardiovascular/ febrile reactions, Table S5 ) with respect to the levels of both proteins. In this unrelated setting, ApoE levels were unaltered among groups. In contrast, ApoA1 was significantly decreased in the postanaphylactic group and in patients with other diseases (Figure 1E,F) . To determine the sensitivity and specificity of ApoE and ApoA1 as biomarkers of anaphylaxis, ROC curve analysis and their corresponding AUC values (Table S6) 
| DISCUSSION
This study was designed to determine suitable biomarkers of anaphylaxis as up to now there is no such marker available to allow a reliable diagnosis. Based on a protein identification report and on literature, 7 we analyzed serum levels of ApoE and ApoA1 in mice and in humans. We found a significant decrease in serum ApoE and ApoA1 levels after anaphylaxis in mice ( Figure 1A ,B).
Lower levels of both proteins have been found in mice upon IgEindependent MC degranulation before 7 and might be explained by the amount of MC derived proteases. 16 It has been shown, indeed, that MC proteases are able to degrade HDL particles. 10, 12, 17, 18 We and others have shown previously 5, 6 that tryptase is a suitable marker for anaphylaxis, when the baseline level of the patient is known. In fact, using matched serum samples from food allergic patients with objective symptoms upon challenge, tryptase levels were likewise increased in the current study (Fig. S1 ). Simultaneously, ApoE and ApoA1 decreased significantly ( Figure 1A-D) ,
although ApoE failed to discriminate between anaphylactic and nonanaphylactic conditions when comparing unrelated groups of patients. In contrast, ApoA1 was significantly decreased in the postanaphylactic group, likely resulting from increased proteolytic activity upon mast cell activation. However, ApoA1 did not discriminate between anaphylaxis and cardiovascular/febrile reactions. Low levels of ApoA1 have been found in patients with chronic cardiovascular reactions 8, 19 but interestingly also in patients with acute conditions like sepsis. 20 Our data suggest that ApoA1 degradation may occur in diverse acute disorders, including cardiovascular, febrile and anaphylactic.
As the focus of our study was to identify whether ApoA1 and ApoE could serve as biomarkers of anaphylaxis, we determined their predictive power to discriminate between anaphylactic and nonanaphylactic patients by ROC curve analysis. ApoE showed poor sensitivity/specificity in discriminating between anaphylactic and F I G U R E 1 Serum levels of ApoE (n=10/group, A) and ApoA1 (n=8/group, B) in mice with and without an anaphylactic response. Passive systemic anaphylaxis was induced as described previously. 14 Blood was taken 70 min after the onset of anaphylaxis. Serum levels of ApoE (C) and ApoA1 (D) prior to and after an oral allergen challenge in the same patient (n=11). Blood was taken a maximum of 15 min after oral challenge, depending on clinical reactivity. Dots corresponding to the same patient are interconnected. Serum levels of ApoE (E) and ApoA1 (F) in nonallergic patients (n=11) versus those of patients who had experienced anaphylaxis in the past but were not having an anaphylactic reaction at the time of blood withdrawal ('ANA prone', n=19) versus those of patients with acute anaphylaxis ('after ANA', blood obtained a maximum of 2 hours after the event, n=10) and patients with cardiovascular or febrile reactions ('other diseases', n=12). ApoE and ApoA1 were assessed via ELISA. A P-value of .05 was considered statistically significant WITTENBERG ET AL. cohorts of patients were analyzed in our study, warranting further studies on the utility of these biomarkers.
| CONCLUSION
Serum levels of ApoA1 decrease during anaphylaxis. ApoA1 and 9a,11ß-PGF 2 combined has high diagnostic power as a composite biomarker of anaphylaxis.
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